CHICAGO--(BUSINESS WIRE)--Chromatin Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin’s proprietary gene stacking technology in sugar cane.
CHICAGO--(BUSINESS WIRE)--Chromatin Inc. announced today that it has entered into an exclusive worldwide research and commercial license agreement with Syngenta Biotechnology Inc. for Chromatin’s proprietary gene stacking technology in sugar cane.